Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

2.

Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.

Chevalier MS, Daniels GM, Johnson DC.

J Virol. 2002 Aug;76(16):8265-75. Erratum in: J Virol 2002 Dec;76(24):13126.

3.

Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.

Johnson DC, Hegde NR.

Curr Top Microbiol Immunol. 2002;269:101-15. Review.

PMID:
12224504
4.
5.

The p97 ATPase dislocates MHC class I heavy chain in US2-expressing cells via a Ufd1-Npl4-independent mechanism.

Soetandyo N, Ye Y.

J Biol Chem. 2010 Oct 15;285(42):32352-9. doi: 10.1074/jbc.M110.131649. Epub 2010 Aug 11.

6.

TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.

Oresic K, Ng CL, Tortorella D.

J Biol Chem. 2009 Feb 27;284(9):5905-14. doi: 10.1074/jbc.M807568200. Epub 2009 Jan 2.

8.

The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins.

Hegde NR, Chevalier MS, Wisner TW, Denton MC, Shire K, Frappier L, Johnson DC.

J Biol Chem. 2006 Jul 28;281(30):20910-9. Epub 2006 May 25.

9.

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11327-33.

10.
11.

Structural and functional analysis of human cytomegalovirus US3 protein.

Misaghi S, Sun ZY, Stern P, Gaudet R, Wagner G, Ploegh H.

J Virol. 2004 Jan;78(1):413-23.

12.
13.

Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.

Lee S, Yoon J, Park B, Jun Y, Jin M, Sung HC, Kim IH, Kang S, Choi EJ, Ahn BY, Ahn K.

J Virol. 2000 Dec;74(23):11262-9.

14.

Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.

Barel MT, Hassink GC, van Voorden S, Wiertz EJ.

Mol Immunol. 2006 Mar;43(8):1258-66. Epub 2005 Aug 10.

PMID:
16098592
15.

Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.

Noriega VM, Tortorella D.

J Virol. 2009 Feb;83(3):1359-67. doi: 10.1128/JVI.01324-08. Epub 2008 Nov 12.

16.

Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.

Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ.

J Immunol. 2003 Dec 15;171(12):6757-65.

17.

Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.

Barel MT, Pizzato N, Le Bouteiller P, Wiertz EJ, Lenfant F.

Int Immunol. 2006 Jan;18(1):173-82. Epub 2005 Dec 16.

PMID:
16361314
18.

Human cytomegalovirus US3 modulates destruction of MHC class I molecules.

Noriega VM, Hesse J, Gardner TJ, Besold K, Plachter B, Tortorella D.

Mol Immunol. 2012 Jun;51(2):245-53. doi: 10.1016/j.molimm.2012.03.024. Epub 2012 Apr 10.

19.

The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.

van der Wal FJ, Kikkert M, Wiertz E.

Curr Top Microbiol Immunol. 2002;269:37-55. Review.

PMID:
12224515
20.

Signal peptide peptidase is required for dislocation from the endoplasmic reticulum.

Loureiro J, Lilley BN, Spooner E, Noriega V, Tortorella D, Ploegh HL.

Nature. 2006 Jun 15;441(7095):894-7. Epub 2006 May 31.

PMID:
16738546

Supplemental Content

Support Center